What was the ENTRUST study and how does this provide context to the AUGUSTUS trial?
Professor Lopes summarises the ENTRUST-AF study comparing edoxaban in a double therapy with a P2Y12 inhibitor vs. warfarin as part of a triple therapy which has been important in adding to the body of knowledge in this field.